Navigation Links
HIV Drug in Microbicide Gel Safe for Daily Use
Date:2/26/2008

None of the 200 women volunteers got HIV during 6-month study

TUESDAY, Feb. 26 (HealthDay News) -- A vaginal microbicide gel that contains the antiretroviral drug tenofovir is safe for HIV-negative women to use every day, according to a six-month study of 200 women in India and the United States.

This study, by researchers at the U.S. National Institutes of Health-funded Microbicide Trials Network, looked at whether women were able to adhere to a regimen of either daily or sex-dependent use of the gel. Both regimens proved equally safe, and women's adherence to each regimen was similar. Notably, none of the women who used the new gel got HIV during the study period.

There were no differences in liver, blood and kidney function between women who used the gel and those who used a placebo, nor were there any differences in rates of genital symptoms such as itching and burning.

The compliance rate was 83 percent among women in the daily use group, and 80 percent among women instructed to use the gel within two hours of having sex.

The results are an advance in efforts to use microbicides to prevent HIV infection in women, the researchers said. Worldwide, almost half of people with HIV/AIDS are women, and 70 percent to 90 percent of all HIV infections in women are due to heterosexual intercourse. In many areas of the world, even married women and those with steady partners are at risk for HIV infection.

Correct and consistent use of male condoms prevents HIV infection, but it's often difficult for some women to convince men to use condoms.

"Finding that daily use is both safe and feasible is important, because we believe a daily approach may provide more sustainable protection against the virus in women who can't always predict when they will have sex," study leader Sharon L. Hillier, said in a prepared statement.

"Based on what we have learned, we can proceed with greater confidence on a path that will answer whether tenofovir gel and other gels with HIV-specific compounds will be able to prevent sexual transmission of HIV in women when other approaches have failed to do so. It is a critical time for all of us engaged in HIV prevention, and I truly believe we are turning a corner," said Hillier, director of reproductive sciences at the University of Pittsburgh School of Medicine.

Microbicides designed to prevent HIV infection are applied on the inside of the vagina or rectum.

The study was presented this week at Microbicides 2008, an international meeting in New Delhi, India.

More information

The U.S. Centers for Disease Control and Prevention has more about HIV/AIDS and women.



-- Robert Preidt



SOURCE: Microbicide Trials Network, news release, Feb. 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide
2. Trial finds tenofovir gel safe for daily use and most women adhered to study regimens
3. Daily Stress May Raise Womens Risk of Cervical Cancer
4. New Renuva Daily Balance Spray Is Designed to Be the Easiest and Best Way to Take Daily Vitamins and Minerals
5. Labopharms Once-Daily Tramadol Approved in South Korea and Australia
6. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
7. Research shows a daily does of beetroot juice can beat high blood pressure
8. FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
9. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
10. Los Angeles Daily Journal Names Richardson & Patel Verdict Top in the State of California for 2007
11. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drug in Microbicide Gel Safe for Daily Use
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment and retention ... and scientific initiatives have all marked the last 12 months at Roswell Park ... of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined the many ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular Dystrophy Association and ... launched the 14th annual “Appetite for a Cure” campaign on Feb. 1 to ... and related diseases that severely limit strength and mobility. , Now through ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... Ontario (PRWEB) , ... February 05, 2016 , ... After ... Scarborough General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned to ... Scarborough Hospital. He successfully completed his first three-year term as chief and began a ...
(Date:2/5/2016)... ... 05, 2016 , ... US Sports Camps , official operators of Nike ... high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in the picturesque New ... ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled to be ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... VIEW, Calif., Feb. 4, 2016  Omnicell, Inc. (NASDAQ: ... management solutions to healthcare systems, today announced results for ... --> --> GAAP ... $130.3 million, up $5.1 million or 4.1% from the ... 7.2% from the fourth quarter of 2014. Revenue for ...
(Date:2/4/2016)... SILVER SPRING, Md. , Feb. 4, 2016 ... Robert Califf , the FDA,s Deputy Commissioner for Medical Products ... far-reaching action plan to reassess the agency,s approach to opioid ... the epidemic, while still providing patients in pain access to ... The FDA will: , Re-examine the risk-benefit ...
(Date:2/4/2016)... India , February 4, 2016 ... the new Market Research Report "North American Automated External ... Fully-Automated External Defibrillators), by End-User (Public Facilities, Hospitals, Homecare ... American automated external defibrillators (AED) report defines and segments ... the revenue. This market is estimated to grow to ...
Breaking Medicine Technology: